Onderzoeker
Lambrecht Bart Norbert
- Disciplines (Flanders Institute for Biotechnology):Analyse van next-generation sequence data, Adaptieve immunologie, Bacteriologie
- Disciplines (Ghent University):Andere medische en gezondheidswetenschappen niet elders geclassificeerd
- Zie ook: Bart Lambrecht (Universiteit Gent)
Affiliaties
- Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf1 okt 2018 → Heden - VIB Center for Inflammation Research (Onderzoekscentrum)
Verantwoordelijke
Vanaf1 jan 2017 → Heden - Lambrecht and Hammad Lab (Onderzoeksgroep)
Verantwoordelijke
Vanaf1 jan 2017 → Heden - Vakgroep Inwendige ziekten (Departement)
Lid
Vanaf1 okt 1994 → 30 sep 2018
Projecten
1 - 7 of 7
- Linking the microbiome and the B cell repertoire to lupus nephritisVanaf1 mei 2022 → 30 jan 2024Financiering: Andere int. instellingen niet elders genoemd
- VIB Grant for Lambrecht and Hammad Lab_Period:2022-01-01-2026-12-31Vanaf1 jan 2022 → HedenFinanciering: VOI - Projectmatig onderzoek
- International PhD Programme for Medical DoctorsVanaf1 jan 2022 → HedenFinanciering: Andere Eu-programma's en intiatieven
- Functional Organization of Immunity by Lymphoid Stromal Cells — Stroma.Org - Marie curie individual fellowship Antonio BaptistaVanaf1 jul 2020 → 30 jun 2022Financiering: HORIZON.1.2 - Marie Skłodowska-Curie-acties (MSCA)
- Eosinophil functional heterogeneity in health and diseaseVanaf1 jul 2020 → 30 jun 2022Financiering: Buitenl. publieke opdrachtgever
- Role of protein crystallization in type 2 immunity and asthmaVanaf1 aug 2018 → 31 jul 2023Financiering: HORIZON.1.1 - European Research Council (ERC)
- VIB Grant for Lambrecht and Hammad Lab_Period:2017-01-01-2021-12-31Vanaf1 jan 2017 → 31 dec 2021Financiering: VOI - Projectmatig onderzoek
Publicaties
1 - 10 van 153
- Sublingual allergen immunotherapy (SLIT) prevents house dust mite inhalant type 2 immunity through DC-mediated induction of Foxp3+ regulatory T cells.(2024)
Auteurs: Eline Haspeslagh, Hamida Hammad, Bart Lambrecht
Pagina's: e-pub - Physicochemical and biological stability of diluted vedolizumab in intravenous infusion bags.(2024)
Auteurs: Kevin Balcaen, Jurgen Haustraete, Bart Lambrecht
Pagina's: e-pub - Modeling T2 high severe asthma using human induced pluripotent stem cells (hiPSC).(2024)
Auteurs: Engi Ahmed, Hamida Hammad, Bart Lambrecht
Pagina's: 289-293 - Ym1 protein crystals promote type 2 immunity.(2024)
Auteurs: Ines Heyndrickx, Kenneth Verstraete, Ursula Smole, Helena Catharine Aegerter, Hamida Hammad, Savvas Savvides, Bart Lambrecht
Pagina's: RP90676 - Lipid Nanoparticle Encapsulation Empowers Poly(I:C) to Activate Cytoplasmic RLRs and Thereby Increases Its Adjuvanticity.(2024)
Auteurs: Bart Lambrecht
Pagina's: e2306892 - CCL5-producing migratory dendritic cells guide CCR5+ monocytes into the draining lymph nodes.(2023)
Auteurs: Bart Lambrecht
Pagina's: e20222129 - Canonical IRE1 function needed to sustain vigorous natural killer cell proliferation during viral infection.(2023)
Auteurs: Jessica Vetters, Sofie Rennen, Eva Cloots, Bart Lambrecht, Sophie Janssens
Pagina's: 108570 - The Pathology of Asthma: What Is Obstructing Our View?(2023)
Auteurs: Helena Catharine Aegerter, Bart Lambrecht
Pagina's: 387-409 - LXR signaling controls homeostatic dendritic cell maturation.(2023)
Auteurs: Victor Bosteels, Sandra Maréchal, Sofie Rennen, Jonathan Maelfait, Simon Tavernier, Jessica Vetters, Julie Van Duyse, Cédric Bosteels, Ria Roelandt, Annelies Emmaneel, et al.
Pagina's: eadd3955 - Protein citrullination and NET formation do not contribute to the pathology of A20/TNFAIP3 mutant mice.(2023)
Auteurs: Karel Van Damme, Pieter Hertens, Arne Martens, Elisabeth Gilis, Dario Priem, Jozefien Declercq, Helena Catharine Aegerter, Andy Wullaert, Esther Hoste, Savvas Savvides, et al.
Pagina's: 17992
Patenten
1 - 4 van 4
- GALECTIN-10 ANTIBODIES (Inventor)
- GALECTIN-10 ANTIBODIES (Inventor)
- GALECTIN-10 ANTIBODIES (Inventor)
- GALECTIN-10 ANTIBODIES (Inventor)